Title: |
Additional BCR-ABL1 Mutations Identified By Sensitive Mass Spectrometry In Chronic Phase CML Patients With T315I Treated With Ponatinib Are Associated With Relatively Inferior Responses and Outcome |
Source: |
Blood
[0006-4971]
Parker,
Wendy
yr:2013
|
|
|
|